SerenQ Heal 10mg Peptide Pen

SerenQ Pharmaceuticals builds research peptides into sealed, pre-filled injection pens rather than lyophilised vials. No reconstitution, no bacteriostatic water, no guesswork with a syringe barrel. Dial the units you need, read them off the window, done. Blends arrive pre-mixed at a fixed ratio, so there is nothing to combine.

SerenQ has appointed The Ped Shop as its exclusive UK stockist. Every pen sold here comes direct from the manufacturer, in sealed retail cartons, with a unique serial number and QR authenticity code on the label.

SerenQ Pharmaceuticals

HEAL

BPC-157 + TB500 · Blended Peptide Injection Pen BPC-157 5mg TB500 5mg Content5mg + 5mg Dial graduation10u = 250 / 250mcg Per unit25 / 25mcg Total units200u FormatPre-filled pen Pen tips32G 0.23 x 4mm Expiry12/2027 AuthenticityQR + serial

Third Party Testing

Results pending

Every SerenQ batch is sent for independent analysis before it goes on general sale. Purity and identity testing for this batch is currently with Analiza, and the certificate will be published on this page the moment it lands.

LaboratoryAnaliza TestPurity & identity MethodHPLC / MS StatusAwaiting report

Check back here for the full certificate, or ask us and we will send it over as soon as it is released.

Serialised & QR Verified

Every SerenQ product carries a unique serial number and a QR code printed on the label. Scan it with any phone camera and you can independently confirm the pen is genuine SerenQ stock and check its batch details before you open the carton.

One code per pen. Each one can only be registered once, so a duplicate scan is an immediate red flag.

About the blend

HEAL holds the two most studied tissue repair peptides in a fixed 1:1 ratio. They are paired so often in the literature that they are almost never discussed separately, and the reason is that they work through completely unrelated mechanisms rather than doubling up on the same one.

BPC-157, short for Body Protection Compound 157, is a synthetic pentadecapeptide, fifteen amino acids taken from a partial sequence of a protective protein found in human gastric juice. It is unusual in remaining stable in gastric acid, which is part of why it appears so often in published work. Animal studies have examined tendon, ligament and muscle fibroblast activity, gastrointestinal mucosal integrity and new blood vessel formation, with the VEGFR2 signalling pathway and the nitric oxide system as recurring areas of investigation.

TB500 is a synthetic fragment of Thymosin Beta-4, a 43 amino acid protein found throughout human tissue and concentrated at sites of injury. TB500 is not the whole protein but the short active region around the sequence LKKTETQ, isolated because the fragment is smaller and more stable to work with. Thymosin Beta-4 is the principal actin sequestering protein in most cells, controlling the pool of building material available to the cytoskeleton, and research has examined how that influences cell migration, blood vessel formation and the way tissue reorganises during repair.

So one is studied largely around signalling and blood supply, the other around the physical machinery cells use to move and rebuild. That separation is the rationale for the pairing: the research interest is in whether two unrelated routes produce more than either does alone.

Where the evidence sits: both compounds are supported almost entirely by animal and in vitro work. Neither has completed large scale human clinical trials, neither holds a medicines licence in the UK or anywhere else, and research on the combination specifically is thinner still than research on each alone. It is supplied here strictly as a laboratory research chemical.

The pen format

This is where SerenQ does things differently. Instead of two lyophilised vials that have to be reconstituted and drawn up separately, both compounds arrive pre-blended in solution, already loaded into a graduated injection pen with a dial and a dose window. The ratio is fixed, so every dial setting gives the same even split.

• 5mg BPC-157 + 5mg TB500 per pen, pre-blended in solution
• 1 unit = 25mcg of each compound
• 10 units on the dial gives 250mcg / 250mcg
• 200 units in total, which works out at 20 full 10 unit draws per pen
• Dial and dose window let you set the exact amount and read it back before dispensing
• 4 screw on pen tips supplied, individually sealed, 32G 0.23 x 4mm
• 4 alcohol swabs supplied
• Protective cap, clip and a rigid retail carton for storage and transport
• Batch number, expiry and serial printed directly on the pen barrel, not just the box

Handling and storage

• Store refrigerated at 2 to 8°C. Do not freeze
• Keep in the outer carton, away from direct light
• Short periods at room temperature during transit are expected and normal
• Use a fresh sealed tip for each dispense and dispose of tips in a sharps container
• Expiry 12/2027 on sealed, correctly stored stock
• Keep out of reach of children and animals

What is in the box

• 1 × SerenQ HEAL, BPC-157 5mg + TB500 5mg pre-filled injection pen
• 4 × sealed pen tips, 32G 0.23 x 4mm
• 4 × alcohol swabs
• Serialised, QR coded retail carton

For research purposes only

This product is sold strictly as a laboratory research chemical. It is not a medicine, not a supplement and not a cosmetic. It is not for human or veterinary consumption, and it is not intended to diagnose, treat, cure or prevent any disease or condition.

Neither BPC-157 nor TB500 is licensed as a medicinal product by the MHRA, the FDA or any other regulator. Nothing on this page should be read as medical advice, a recommendation, or a suggestion of use in humans or animals.

By purchasing you confirm you are 18 or over, that you are acquiring this product for legitimate laboratory research or analytical use only, and that you accept full responsibility for its safe handling, storage and lawful use under the regulations that apply where you are.